Login / Signup

Influence of Dose Intensity in Consolidation with HIDAC and Other Clinical and Biological Parameters in the Survival of AML.

Ricardo Ballesteros-RamírezSandra QuijanoJulio SolanoCamila Ordoñez-ReyesMaría V HerreraRául MurilloSusana FiorentinoMónica Arevalo-Zambrano
Published in: Journal of cancer epidemiology (2020)
This retrospective study allowed us to know the epidemiology of AML in a reference Colombian Hospital. Additionally, in our knowledge, it is the first study that reports the RDI in consolidation with HIDAC in Latin America as a prognostic factor that directly impacts the OS.
Keyphrases
  • prognostic factors
  • acute myeloid leukemia
  • healthcare
  • adverse drug
  • allogeneic hematopoietic stem cell transplantation
  • risk factors
  • high intensity
  • acute lymphoblastic leukemia